Owlet Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Owlet şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

-19.7%

Geri Alım Getirisi

Toplam Hissedar Getirisi	-19.7%
Gelecekteki Temettü Verimi	0%
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

Many Still Looking Away From Owlet, Inc. (NYSE:OWLT)

Oct 18

Investors Continue Waiting On Sidelines For Owlet, Inc. (NYSE:OWLT)

Jul 18

Owlet, Inc. (NYSE:OWLT) Just Reported Earnings, And Analysts Cut Their Target Price

May 09

Potential Upside For Owlet, Inc. (NYSE:OWLT) Not Without Risk

Feb 29

Owlet, Inc. (NYSE:OWLT) Just Reported And Analysts Have Been Cutting Their Estimates

Nov 17

Owlet Non-GAAP EPS of -$0.17, revenue of $17.4M

Nov 14

Owlet seeks FDA medical device approval for its prescription monitor for infants

Oct 06

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: OWLT şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: OWLT şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Owlet Piyasaya Karşı Temettü Getirisi

OWLT temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (OWLT)	n/a
Pazarın Alt %25'i (US)	1.4%
Pazarın En İyi %25'i (US)	4.2%
Sektör Ortalaması (Medical Equipment)	1.6%
Analist tahmini (OWLT) (3 yıla kadar)	0%

Önemli Temettü: OWLT şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, OWLT şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: OWLT şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: OWLT herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Owlet Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

Consensus EPS estimates fall by 68%

No longer forecast to breakeven

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Owlet, Inc. Updates Financial Guidance for the Full Year 2024

Owlet, Inc. to Report Q3, 2024 Results on Nov 13, 2024

Many Still Looking Away From Owlet, Inc. (NYSE:OWLT)

Owlet Regains Compliance with NYSE Continued Listing Standards

Owlet, Inc. has completed a Follow-on Equity Offering in the amount of $11.600003 million.

Owlet, Inc. has completed a Follow-on Equity Offering in the amount of $11.600003 million.

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Forecast to breakeven in 2026

Owlet, Inc. Provides Earnings Guidance for Second Half and Fiscal Year 2024

Consensus EPS estimates fall by 74%

New minor risk - Profitability

Investors Continue Waiting On Sidelines For Owlet, Inc. (NYSE:OWLT)

Owlet, Inc. Announces Chief Financial Officer Changes

Owlet, Inc., Annual General Meeting, Aug 16, 2024

Consensus EPS estimates upgraded to US$0.57 loss

Owlet, Inc. (NYSE:OWLT) Just Reported Earnings, And Analysts Cut Their Target Price

No longer forecast to breakeven

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Owlet, Inc. to Report Q1, 2024 Results on May 06, 2024

Consensus EPS estimates fall by 24%

Forecast to breakeven in 2026

No longer forecast to breakeven

New major risk - Revenue and earnings growth

Potential Upside For Owlet, Inc. (NYSE:OWLT) Not Without Risk

Owlet, Inc. announced that it expects to receive $9.25 million in funding from Eclipse Ventures, LLC, Trilogy Equity Partners

Owlet, Inc. to Report Q4, 2023 Results on Mar 07, 2024

Owlet, Inc. Provides Unaudited Earnings Guidance for the Fourth Quarter of 2023

Owlet Transforms Infant Care with the Launch of Two FDA-Cleared Devices - Dream Sock®? and BabySat™

Forecast to breakeven in 2026

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

New minor risk - Profitability

Owlet Achieves De Novo FDA-Clearance for Dream Sock – the First and Only Over-The-Counter, Medical Grade Pulse Oximeter Cleared for Infants

Owlet, Inc. to Report Q3, 2023 Results on Nov 13, 2023

High number of new directors

Consensus revenue estimates decrease by 14%, EPS upgraded

Owlet, Inc. Announces Resignation of Jayson Knafel from the Board

No longer forecast to breakeven

High number of new directors

Owlet, Inc. to Report Q2, 2023 Results on Aug 14, 2023

Owlet, Inc. Appoints Jonathan Harris as New President and Chief Revenue Officer

Owlet Appoints Melissa Gonzales to Board of Directors

Consensus EPS estimates upgraded to US$1.82 loss, revenue downgraded

Price target decreased by 50% to US$13.49

Owlet, Inc. Announces 1-For-14 Reverse Stock Split to Regain Compliance

New minor risk - Insider selling

CFO & Principal Accounting Officer recently sold US$122k worth of stock

Owlet Announces FDA-Clearance of the First Prescription Pulse Oximetry Sock for Infants

New major risk - Share price stability

Forecast to breakeven in 2025

Price target decreased by 10% to US$1.93

Owlet, Inc., Annual General Meeting, Jun 23, 2023

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Forecast to breakeven in 2025

Forecast to breakeven in 2025

Owlet, Inc. Announces FDA Software-As-A-Medical Device Submission for Heart Rate and Oxygen Displays and Notifications

Owlet Receives Notice Regarding NYSE Continued Listing Standards

Consensus EPS estimates fall by 18%

Owlet, Inc. (NYSE:OWLT) Just Reported And Analysts Have Been Cutting Their Estimates

No longer forecast to breakeven

Third quarter 2022 earnings: EPS misses analyst expectations

Owlet, Inc. Provides Earnings Guidance of the Year 2022 and Revenue Guidance of the Year 2023

Owlet Non-GAAP EPS of -$0.17, revenue of $17.4M

Owlet, Inc. to Report Q3, 2022 Results on Nov 14, 2022

Owlet, Inc. Provides Revenue Guidance for the Third Quarter Ended September 30, 2022

Owlet, Inc. Announces FDA 510(K) Submission for Prescription Pediatric Monitor

Owlet seeks FDA medical device approval for its prescription monitor for infants

Owlet, Inc. Appoints Kurt Workman as President of the Company

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin